Sign In
Buy MTSR
$70.50
+0 (+0%)
At Close: Feb 12, 2026
IP Group shares jump 9% as Metsera deal drives return to growth
04:46am, Tuesday, 17'th Mar 2026
Shares in IP Group PLC (LSE:IPO) rose 9% to 53.5p on Monday after the company reported net asset value per share climbing to 110.4p, with total NAV reaching £975.1 million. The recovery was driven la
Metsera Inc. (NASDAQ:MTSR) Given Average Recommendation of “Hold” by Brokerages
01:10am, Monday, 08'th Dec 2025
Metsera Inc. (NASDAQ: MTSR - Get Free Report) has been given a consensus rating of "Hold" by the eight analysts that are presently covering the firm, Marketbeat Ratings reports. One investment analyst
Why Is Everyone Talking About Novo Nordisk Stock?
06:15am, Friday, 14'th Nov 2025
There is hardly a dull moment for the drugmaker these days.
Pfizer Completes Acquisition of Metsera
11:26am, Thursday, 13'th Nov 2025
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biopharmaceutical company accelerating
Metsera shareholders vote for $10 billion acquisition by Pfizer
09:18am, Thursday, 13'th Nov 2025
Metsera shareholders on Thursday approved Pfizer's takeover offer worth up to $10 billion, allowing the U.S. pharmaceutical giant re-entry into the lucrative obesity treatment market after a fierce bi
Why Metsera's Share Price Is Plummeting This Week
04:35am, Wednesday, 12'th Nov 2025
Metsera was the target of a bidding war by pharma giants. The company has an innovative obesity drug candidate.
Instacart Up on Earnings Beat; Metsera Down on Takeover Battle | Stock Movers
04:28pm, Monday, 10'th Nov 2025
On this episode of Stock Movers with Lisa Mateo: - Metsera (MTSR) shares tank in premarket trading after Novo Nordisk A/S declined to further raise its offer for the US maker of an experimental weight
Pfizer to acquire Metsera after winning bidding contest against Novo Nordisk
11:53am, Monday, 10'th Nov 2025
Metsera (NASDAQ:MTSR) announced that it has entered into an amended merger agreement with Pfizer Inc (NYSE:PFE, ETR:PFE), under which Pfizer will acquire the biotech company for up to $86.25 per shar
Pfizer to buy Metsera in deal worth up to $10 billion
10:30am, Monday, 10'th Nov 2025
Pfizer has clinched a $10 billion deal for obesity drug developer Metsera, capping a fierce biotech bidding war between the New York-based pharma giant and Danish rival Novo Nordisk. Metsera accepted
Pfizer CEO: Metsera deal gives us 'one of the most exciting, advanced portfolios' in obesity drugs
10:21am, Monday, 10'th Nov 2025
Pfizer CEO Albert Bourla joins Squawk on the Street to discuss the company's up to $10 billion acquisition of Metsera, the competitive landscape in obesity drugs, and Pfizer's strategy for clinical de
5 Things to Know Before the Stock Market Opens
09:10am, Monday, 10'th Nov 2025
Stock futures are surging this morning after U.S. lawmakers passed a key procedural hurdle as part of an agreement that could bring an end to the shutdown that has lasted nearly six weeks; President D
Pfizer Is Buying Weight-Loss Drugmaker Metsera. Why Novo Nordisk Is the Winner.
07:32am, Monday, 10'th Nov 2025
The Danish drugmaker's shareholders appear relieved that it hasn't overpaid for largely unproven treatments.
Monday.Com, Metsera, Profrac Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session
06:18am, Monday, 10'th Nov 2025
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 1.5% on Monday.
Novo Nordisk Shares Rise After Withdrawal from Metsera Takeover Battle
04:38am, Monday, 10'th Nov 2025
Shares climbed as much as 3.5% in early European trade after Pfizer agreed to buy Metsera in a deal that could be worth more than $10 billion following a heated takeover battle.
Novo Nordisk shares rise after dropping Metsera bid
03:05am, Monday, 10'th Nov 2025
Shares in Novo Nordisk NOVOb.CO rose in early trade on Monday, after the Wegovy-maker on Saturday dropped its bid for U.S. weight loss drug company Metsera, ending a bidding war with rival Pfizer.
